1. Home
  2. VNCE vs SPRO Comparison

VNCE vs SPRO Comparison

Compare VNCE & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$5.10

Market Cap

82.0M

ML Signal

HOLD

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNCE
SPRO
Founded
2002
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.0M
71.0M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
VNCE
SPRO
Price
$5.10
$1.14
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$5.17
N/A
AVG Volume (30 Days)
96.4K
438.2K
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
132.45
111.81
EPS
N/A
N/A
Revenue
$300,007,000.00
$66,802,000.00
Revenue This Year
$5.86
N/A
Revenue Next Year
N/A
$300.00
P/E Ratio
N/A
N/A
Revenue Growth
2.23
39.24
52 Week Low
$1.95
$1.08
52 Week High
$8.20
$3.08

Technical Indicators

Market Signals
Indicator
VNCE
SPRO
Relative Strength Index (RSI) 34.97 29.73
Support Level $3.99 $1.13
Resistance Level $5.90 $1.29
Average True Range (ATR) 0.50 0.04
MACD -0.12 0.01
Stochastic Oscillator 1.90 0.00

Price Performance

Historical Comparison
VNCE
SPRO

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: